PF-06866681

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06866681, covering 2019-06-17 to 2019-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children [Phase 3]